P. Erbel

2.3k total citations
29 papers, 1.5k citations indexed

About

P. Erbel is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, P. Erbel has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in P. Erbel's work include Glycosylation and Glycoproteins Research (7 papers), Bacteriophages and microbial interactions (3 papers) and Cell death mechanisms and regulation (3 papers). P. Erbel is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Bacteriophages and microbial interactions (3 papers) and Cell death mechanisms and regulation (3 papers). P. Erbel collaborates with scholars based in Switzerland, United States and Netherlands. P. Erbel's co-authors include Kevin H. Gardner, Paul B. Card, Martin Renatus, A. D’Arcy, Nikolaus Schiering, Richard K. Bruick, Siew Pheng Lim, Ulrich Hommel, Zheng Yin and Thomas H. Keller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

P. Erbel

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Erbel Switzerland 19 760 419 287 193 160 29 1.5k
S. Frank Yan United States 20 1.3k 1.7× 561 1.3× 135 0.5× 121 0.6× 247 1.5× 33 2.2k
Alexander E. Aleshin United States 28 1.3k 1.7× 383 0.9× 212 0.7× 236 1.2× 178 1.1× 53 2.5k
Bryan T. Mott United States 22 1.3k 1.6× 316 0.8× 478 1.7× 222 1.2× 106 0.7× 44 2.1k
Maria Cristina Nonato Brazil 22 944 1.2× 210 0.5× 69 0.2× 199 1.0× 76 0.5× 76 1.4k
John P. Priestle Switzerland 18 889 1.2× 303 0.7× 46 0.2× 169 0.9× 93 0.6× 32 1.4k
René Coulombe Canada 19 768 1.0× 84 0.2× 218 0.8× 295 1.5× 85 0.5× 33 1.5k
Ross I. Brinkworth Australia 23 988 1.3× 118 0.3× 65 0.2× 181 0.9× 150 0.9× 41 1.6k
Ted Fox United States 18 1.3k 1.7× 75 0.2× 190 0.7× 198 1.0× 141 0.9× 24 2.0k
Stefania Di Marco Italy 22 1.8k 2.4× 117 0.3× 97 0.3× 249 1.3× 252 1.6× 32 2.6k
Stephen A. Margosiak United States 21 925 1.2× 76 0.2× 177 0.6× 133 0.7× 74 0.5× 28 1.6k

Countries citing papers authored by P. Erbel

Since Specialization
Citations

This map shows the geographic impact of P. Erbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Erbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Erbel more than expected).

Fields of papers citing papers by P. Erbel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Erbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Erbel. The network helps show where P. Erbel may publish in the future.

Co-authorship network of co-authors of P. Erbel

This figure shows the co-authorship network connecting the top 25 collaborators of P. Erbel. A scholar is included among the top collaborators of P. Erbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Erbel. P. Erbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dekker, Carien, Henri Mattes, Michael Wright, et al.. (2021). Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition. Journal of Molecular Biology. 433(24). 167309–167309. 101 indexed citations
3.
Heiser, Diane, P. Erbel, Achim Schlapbach, et al.. (2021). Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1. Biochemical and Biophysical Research Communications. 545. 177–182. 12 indexed citations
4.
Quancard, Jean, Théo Klein, Shan‐Yu Fung, et al.. (2019). An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nature Chemical Biology. 15(3). 304–313. 41 indexed citations
5.
Schlapbach, Achim, Láśzló Révész, Carole Pissot‐Soldermann, et al.. (2018). N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity. Bioorganic & Medicinal Chemistry Letters. 28(12). 2153–2158. 18 indexed citations
6.
Vulpetti, Anna, Nils Ostermann, Stefan Randl, et al.. (2018). Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D. ACS Medicinal Chemistry Letters. 9(5). 490–495. 7 indexed citations
7.
Grosche, Philipp, Finton Sirockin, A. Mac Sweeney, et al.. (2014). Structure-based design and optimization of potent inhibitors of the adenoviral protease. Bioorganic & Medicinal Chemistry Letters. 25(3). 438–443. 15 indexed citations
8.
Wiesmann, Christian, Lukas Leder, Jutta Blank, et al.. (2012). Structural Determinants of MALT1 Protease Activity. Journal of Molecular Biology. 419(1-2). 4–21. 72 indexed citations
9.
Boettcher, Andreas, Simon Ruedisser, P. Erbel, et al.. (2010). Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12. SLAS DISCOVERY. 15(9). 1029–1041. 29 indexed citations
10.
Sweeney, A. Mac, Shirley Gil-Parrado, Anna Bernardi, et al.. (2008). Structural Basis for the Substrate Specificity of Bone Morphogenetic Protein 1/Tolloid-like Metalloproteases. Journal of Molecular Biology. 384(1). 228–239. 42 indexed citations
11.
D’Arcy, A., Maxime Chaillet, Nikolaus Schiering, et al.. (2006). Purification and crystallization of dengue and West Nile virus NS2B–NS3 complexes. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 62(2). 157–162. 16 indexed citations
12.
Erbel, P., Nikolaus Schiering, A. D’Arcy, et al.. (2006). Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nature Structural & Molecular Biology. 13(4). 372–373. 458 indexed citations
13.
Yang, Jinsong, Lei Zhang, P. Erbel, et al.. (2005). Functions of the Per/ARNT/Sim Domains of the Hypoxia-inducible Factor. Journal of Biological Chemistry. 280(43). 36047–36054. 70 indexed citations
14.
Card, Paul B., P. Erbel, & Kevin H. Gardner. (2005). Structural Basis of ARNT PAS-B Dimerization: Use of a Common Beta-sheet Interface for Hetero- and Homodimerization. Journal of Molecular Biology. 353(3). 664–677. 111 indexed citations
15.
Erbel, P., Ronald Seidel, Lisa Gentile, et al.. (2004). Cyclic enterobacterial common antigen: Potential contaminant of bacterially expressed protein preparations. Journal of Biomolecular NMR. 29(2). 199–204. 10 indexed citations
16.
Erbel, P., et al.. (2003). Structural basis for PAS domain heterodimerization in the basic helix–loop–helix-PAS transcription factor hypoxia-inducible factor. Proceedings of the National Academy of Sciences. 100(26). 15504–15509. 190 indexed citations
17.
Erbel, P., et al.. (2003). Identification and Biosynthesis of Cyclic Enterobacterial Common Antigen in Escherichia coli. Journal of Bacteriology. 185(6). 1995–2004. 48 indexed citations
18.
Erbel, P., Simon R. Haseley, Johannis P. Kamerling, & Johannes F.G. Vliegenthart. (2002). Studies on the relevance of the glycan at Asn-52 of the α-subunit of human chorionic gonadotropin in the αβ dimer. Biochemical Journal. 364(2). 485–495. 17 indexed citations
19.
Leeflang, Bas R., Elisabeth J. Faber, P. Erbel, & Johannes F.G. Vliegenthart. (2000). Structure elucidation of glycoprotein glycans and of polysaccharides by NMR spectroscopy. Journal of Biotechnology. 77(1). 115–122. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Frank Yan Breakdown of academic impact, for papers by Alexander E. Aleshin Breakdown of academic impact, for papers by Bryan T. Mott Breakdown of academic impact, for papers by Maria Cristina Nonato Breakdown of academic impact, for papers by John P. Priestle Breakdown of academic impact, for papers by René Coulombe Breakdown of academic impact, for papers by Ross I. Brinkworth Breakdown of academic impact, for papers by Ted Fox Breakdown of academic impact, for papers by Stefania Di Marco Breakdown of academic impact, for papers by Stephen A. Margosiak
Rankless by CCL
2026